Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

被引:0
作者
Mahmoud Ganji
Shohreh Bakhshi
Alireza Shoari
Reza Ahangari Cohan
机构
[1] Tarbiat Modares University,Department of Medical Biotechnology, Faculty of Medical Sciences
[2] Tehran University of Medical Sciences,Faculty of Pharmacy
[3] Pasteur Institute of Iran,Biotechnology Research Center
[4] Pasteur Institute of Iran,Department of Nanobiotechnology, New Technologies Research Group
来源
Journal of Translational Medicine | / 21卷
关键词
Bladder cancer; Drug discovery; Pharmacophore; QSAR; Docking; Molecular dynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 316 条
[1]  
Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[2]  
Ferlay J(2021)New approaches and procedures for cancer treatment: current perspectives SAGE Open Med 9 20503121211034370-433
[3]  
Siegel RL(2021)Bladder and upper urinary tract cancers as first and second primary cancers Cancer Rep 4 420-104
[4]  
Laversanne M(2020)A consensus molecular classification of muscle-invasive bladder cancer Eur Urol 77 289-296
[5]  
Soerjomataram I(2015)Non-muscle invasive bladder cancer risk stratification Indian J Urol 31 80-35
[6]  
Jemal A(2014)Multimodal management of muscle invasive bladder cancer Curr Probl Cancer 38 82-266
[7]  
Debela DT(2021)European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines Eur Urol 79 131-15297
[8]  
Muzazu SGY(2021)Immune checkpoint inhibitors for the treatment of bladder cancer Cancers (Basel) 13 285-38
[9]  
Heraro KD(2018)Immune checkpoint inhibitors for urothelial carcinoma Investig Clin Urol 59 1-343
[10]  
Ndalama MT(2021)Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer Signal Transduct Target Ther 6 215-e1719